BioLineRx licenses compound for neuropathic and inflammatory pain
08 September 2011
Nancy Faigen
Please Login to read the full article.
08 September 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mérieux and Shire funds back NeuroPhage in $12.4 million round for Alzheimer's
- UK govt offers "step change" in support for regenerative medicine
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Acura investors euphoric over US FDA OK of oxycodone painkiller
FEATURES
Other Informa Features
